Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lieber

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Sexual Medicine|July 3, 2009
Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among menNaomi M Gades, Debra J Jacobson, Michaela E McGree, et al.
BJU International|September 1, 2010
Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptomsJennifer L St Sauver, Steven J Jacobsen, Debra J Jacobson, et al.
American Journal of Epidemiology|April 28, 2009
Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohortJennifer L St Sauver, Aruna V Sarma, Debra J Jacobson, et al.
Mayo Clinic Proceedings|February 3, 2009
A population-based, longitudinal study of erectile dysfunction and future coronary artery diseaseBrant A Inman, Jennifer L St Sauver, Debra J Jacobson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2002
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progressionJunqi Qian, Kiyoshi Hirasawa, David G Bostwick, et al.
Urology|November 25, 2011
Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white menAruna V Sarma, Jennifer L St Sauver, John M Hollingsworth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancerDonkena Krishna Vanaja, Karla V Ballman, Bruce W Morlan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County studyLauren P Wallner, Aruna V Sarma, Michael M Lieber, et al.
American Journal of Epidemiology|February 5, 2005
Association between smoking and erectile dysfunction: a population-based studyNaomi M Gades, Ajay Nehra, Debra J Jacobson, et al.
Urology|August 31, 2010
Estimation of prostate size in community-dwelling menDebra J Jacobson, Jennifer L St Sauver, Alexander S Parker, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Sexual Medicine|July 3, 2009
Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among menNaomi M Gades, Debra J Jacobson, Michaela E McGree, et al.
BJU International|September 1, 2010
Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptomsJennifer L St Sauver, Steven J Jacobsen, Debra J Jacobson, et al.
American Journal of Epidemiology|April 28, 2009
Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohortJennifer L St Sauver, Aruna V Sarma, Debra J Jacobson, et al.
Mayo Clinic Proceedings|February 3, 2009
A population-based, longitudinal study of erectile dysfunction and future coronary artery diseaseBrant A Inman, Jennifer L St Sauver, Debra J Jacobson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2002
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progressionJunqi Qian, Kiyoshi Hirasawa, David G Bostwick, et al.
Urology|November 25, 2011
Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white menAruna V Sarma, Jennifer L St Sauver, John M Hollingsworth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancerDonkena Krishna Vanaja, Karla V Ballman, Bruce W Morlan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County studyLauren P Wallner, Aruna V Sarma, Michael M Lieber, et al.
American Journal of Epidemiology|February 5, 2005
Association between smoking and erectile dysfunction: a population-based studyNaomi M Gades, Ajay Nehra, Debra J Jacobson, et al.
Urology|August 31, 2010
Estimation of prostate size in community-dwelling menDebra J Jacobson, Jennifer L St Sauver, Alexander S Parker, et al.
Pageof 9